The accelerated FDA approval of Bayer's Hyrnuo covers treatment of advanced cases of non-small cell lung cancer with HER2 ...

Function Health raised a $298 million Series B round, pushing its valuation into unicorn territory at $2.5 billion. The ...

The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

An experimental MeiraGTx gene therapy that has clinical data showing reversal of blindness in children born with a rare, inherited eye disorder is heading to Eli Lilly. According to the terms of the ...

Amid growing pressure on the U.S. healthcare system to meet the needs of its aging population, the Digital Medicine Society (DiMe) launched a new initiative this month to build a roadmap for ...

The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products, which are often used to treat menopause, the Department of Health and Human Services ...

As the nation’s healthcare industry continues to struggle with workforce shortages and access gaps, Philips is expanding beyond its traditional medtech roots. The company isn’t just selling monitoring ...

From Left to Right: Arundhati Parmar, editor-in-chief, MedCity News; Dickon Waterfield, president, Lantern; Darcy Sementi, healthcare benefits manager, State Farm ...

About one in six working adults in the U.S. battle a substance use disorder, and nearly 10% of U.S. employees have a cannabis or stimulant use disorder. Recognizing this, Carrum Health has expanded ...

How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are ...

From L to R Paige Minemyer, Senior Writer, Fierce Healthcare; Dr. James Metcalf, Regional Chief Medical Officer, Medicare & Retirement, Optum; Puneet Maheshwari, GM, Optum Real; Pete Clardy, Senior ...